Diabetic Complications - Innovative And Diverse Neuropathies, Nephropathy And Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies
Access Full Report: http://www.marketresearchreports.biz/analysis/759625
The lack of absolute treatment for the condition and the difficulty in maintaining constant glycemic control, even following adequate treatment, can result in a range of complications. The three main indication groups are diabetic nephropathy, which is a progressive condition caused by damage to the capillaries and kidneys glomeruli as a result of diabetes; diabetic retinopathy, which is defined as damage to the retina as a result of high blood sugar; and a range of diabetic neuropathies, a group of conditions in which nerve damage is caused as a result of diabetes mellitus.
The need for improved therapeutics within diabetic complications is especially prominent in comparison with other multi-systemic conditions, as the market is currently predominantly composed of therapies that symptomatically treat the condition, or at best slow disease progression. However, as the understanding of disease pathophysiology in both diabetes and its complications increases, new targets are being identified and converted into improved therapeutic options that are better aligned with the underlying disease pathophysiology than their predecessors.
The diabetic complications pipeline consists of 429 products that contain an array of targets not currently in use within the market. The increase in molecular target diversity signifies the high potential for changes and improvements in the diabetic complications market. One innovative therapy is CBX-129801, a promising synthetic peptide that is currently in development for diabetic neuropathy. Innovation can also be seen within diabetic retinopathy, with therapies such as BCN070660, a topical ophthalmologic formulation currently in development.
Complete Outlook And Sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/759625
What effect do current market therapies have on disease progression?
Which drug classes dominate the current market?
What additional benefits have newly approved therapies brought to the market?
Can the increasing number of peptides in the pipeline prove useful in diabetic neuropathy?
Can neuroprotective therapies prove an important addition in diabetic retinopathies?
Can the diverse range of molecule types and molecular targets within the pipeline help reverse disease progression?
To what degree is the pipeline penetrated by first-in-class innovation?
What is the clinical potential of first-in-class products, based on their alignment to disease-causing pathways?
Which are the most promising first-in-class targets in early-stage development?
Which of the first-in-class products in development are not currently involved in a licensing or co-development deal, and therefore represent investment opportunities?
Reasons To Buy
Understand the current clinical and commercial landscape. It includes a comprehensive study of disease pathogenesis, diagnosis, prognosis and the treatment options available.
Visualize the composition of the market for each diabetic complication individually, in terms of dominant molecule types and targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
Analyze the pipeline for each diabetic complication individually and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking more innovative approaches to treating diabetic complications.
Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
Identify commercial opportunities in the diabetic complications deals landscape by analyzing trends in licensing and co-development deals and producing a curated list of diabetic complications therapies that are not yet involved in deals, and may be potential investment opportunities.
Marketresearchreports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients.
90 State Street, Suite 700
Albany, NY 12207
Toll Free: 866-997-4948
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Complications - Innovative And Diverse Neuropathies, Nephropathy And Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies here
News-ID: 350762 • Views: 451
More Releases from http://www.marketresearchreports.biz/
Health Promoting Wellness Tourism Market Research, Rising Demand To Drive Global …
People traveling to domestic or foreign locations and staying for not more than one consecutive year for business, leisure, and other purposes are defined as tourists. Tourism is one of the major sources of income for many countries. It positively affects the economy of both the source and host countries. View Report: http://www.marketresearchreports.biz/analysis/768139 Technavios analysts forecast the global wellness tourism market to grow at a CAGR of -10.69% during the period 2016-2020. Covered
Application Lifecycle Management (ALM) Market (By Component - Software, Services …
This report on the global ALM market provides analysis for the period from 2013 to 2023, wherein 2014 is the base year and the years from 2015 to 2023 are the forecast period. Data for 2013 has been included as historical information. The report covers all the prevalent trends and technologies playing a major role in the growth of the ALM market over the forecast period. It also highlights various
Cardiac Rehabilitation Market Analysis, Size, Share, Growth, Trends, And Forecas …
Increasing burden of cardiovascular diseases has made the global population realize the importance of physical activities in daily routine. This has increased demand for cardiac rehabilitation programs. Such programs help the patients to recover early from any previous cardiac strokes. A cardiac rehabilitation program is a comprehensive activity, which is continuously monitored in order to assist the population to improve their lifestyle. Various cardiovascular risk parameters are monitored and are
Global Wireless Smart Lighting Control System Consumption 2016 Market Research R …
The Global Wireless Smart Lighting Control system Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Wireless Smart Lighting Control system market. Access Report: http://www.marketresearchreports.biz/analysis/763107 First, the report provides a basic overview of the Wireless Smart Lighting Control system industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the
More Releases for Diabetes
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their
Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
Diabetes Drugs Market: Increasing Prevalence of Diabetes to Stoke Market Growth
According to the TMR report, the global diabetes drugs market stood at a valuation of US$43.1 bn in 2016 and is likely to be valued at US$58.4 bn by the end of 2025 expanding at a CAGR of 3.6% between 2017 and 2025. Research and Development Pursuits to Introduce Novel Products Stokes Growth The rising per capita income in several parts of world leading to changing lifestyles and adoption of unhealthy food